Sequel Med Tech connects twiist insulin pump to Abbott’s CGM ahead of market debut

Greenlit for people ages six and older with Type 1 diabetes, Sequel’s twiist system is slated to begin its commercial launch by the end of June.

Mar 18, 2025 - 17:01
 0
Sequel Med Tech connects twiist insulin pump to Abbott’s CGM ahead of market debut
Greenlit for people ages six and older with Type 1 diabetes, Sequel’s twiist system is slated to begin its commercial launch by the end of June.